JPMorgan Chase & Co.
JPMORGAN CHASE & CO (Form: 8-K, Received: 07/02/2014 06:00:29)
 
 
 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K

CURRENT REPORT
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934

Date of Report (date of earliest event reported): July 1, 2014

JPMorgan Chase & Co.
(Exact name of registrant as specified in its charter)
Delaware
1-5805
13-2624428
(State or other jurisdiction of
incorporation or organization)
(Commission File Number)
(I.R.S. employer
identification no.)
 
 
 
270 Park Avenue, New York, New York
 
10017
(Address of principal executive offices)
 
(Zip Code)

Registrant’s telephone number, including area code: (212) 270-6000


Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

o
 
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o
 
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o
 
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o
 
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 
 









Item 8.01 Other Events

On July 1, 2014, Jamie Dimon, Chairman and Chief Executive Officer of JPMorgan Chase & Co. issued a letter to colleagues and shareholders informing them of a recently diagnosed medical condition. A copy of his letter is attached as Exhibit 99.1.


Item 9.01 Financial Statements and Exhibits
(d) Exhibits
Exhibit No.
 
Description of Exhibit
99.1
 
Letter of Jamie Dimon, Chairman and Chief Executive Officer of JPMorgan Chase & Co.










2



SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
JPMorgan Chase & Co.
(Registrant)


By:
/s/ Anthony J. Horan
 
Anthony J. Horan
 
Corporate Secretary


Dated:
July 1, 2014




3






INDEX TO EXHIBITS

Exhibit No.
 
Description of Exhibit
99.1
 
Letter of Jamie Dimon, Chairman and Chief Executive Officer of JPMorgan Chase & Co.





4
Exhibit 99.1



Dear Colleagues and Shareholders -
I wanted to let you know that I have just been diagnosed with throat cancer. The good news is that the prognosis from my doctors is excellent, the cancer was caught quickly, and my condition is curable. Following thorough tests that included a CAT scan, PET scan and a biopsy, the cancer is confined to the original site and the adjacent lymph nodes on the right side of my neck. Importantly, there is no evidence of cancer elsewhere in my body.
My evaluation and treatment plan are still being finalized, but at this time it appears I will begin radiation and chemotherapy treatment shortly at Memorial Sloan Kettering Hospital, which should take approximately eight weeks. While the treatment will curtail my travel during this period, I have been advised that I will be able to continue to be actively involved in our business, and we will continue to run the company as normal. Our Board has been fully briefed and is totally supportive.
As you all know, we have outstanding leaders across our businesses and functions - the best team I’ve ever had the privilege of working with - so our company will move forward together with confidence as we continue to deliver first-class results for our customers, communities and shareholders.
I feel very good now and will let all of you know if my health situation changes.
I appreciate your support and want to thank our employees for the amazing work they do day-in and day-out. I’m very proud to be part of this company and honored to be working with such an exceptional group of people.
Jamie